For research use only. Not for therapeutic Use.
(+)-TK216 is an enantiomer of TK216 (HY-122903). TK216 is an orally active and potent E26 transformation specific (ETS) inhibitor[1][2].
(+)-TK216 (compound 13; for 3 days) has an IC50>5 μM in SKES cells (Ewing Sarcoma cell line)[1].
(+)-TK216 has T1/2s of 103.4 mins, 3.6 mins, 26.6 mins and 8.4 mins for human, rat, mouse, dog liver microsomes[1].
Catalog Number | I045509 |
CAS Number | 1903783-77-6 |
Molecular Formula | C19H15Cl2NO3 |
Purity | ≥95% |
Reference | [1]. Spriano F, et al. The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents. Clin Cancer Res. 2019 Aug 15;25(16):5167-5176. [2]. Jean-Michael Vernier, et al. Indolinone compounds and uses thereof. WO2016057698A1. |